Yu-Ning Wong, MD, MSCE

Articles by Yu-Ning Wong, MD, MSCE

Provider and Patient Burdens of Obtaining Oral Anticancer Medications

ByDaniel M. Geynisman, MD,Caitlin R. Meeker, MPH,Jamie L. Doyle, MPH,Elizabeth A. Handorf, PhD,Marijo Bilusic, MD, PhD,Elizabeth R. Plimack, MD, MS,Yu-Ning Wong, MD, MSCE

April 6th 2018

Oral anticancer medications are frequently used to treat patients with cancer. We found significant time and energy burdens for clinic staff and patients in obtaining these drugs.

Letter to the Editors: Response to Payer Coverage for Patients Enrolled Onto Clinical Trials

ByYu-Ning Wong, MD, MSCE,Jeffery Ward, MD,Michael Neuss, MD

November 16th 2012

Latest Updated Articles

Provider and Patient Burdens of Obtaining Oral Anticancer Medications
April 6th 2018
Letter to the Editors: Response to Payer Coverage for Patients Enrolled Onto Clinical Trials
November 16th 2012

Yu-Ning Wong, MD, MSCE

Articles by Yu-Ning Wong, MD, MSCE

Provider and Patient Burdens of Obtaining Oral Anticancer Medications

Letter to the Editors: Response to Payer Coverage for Patients Enrolled Onto Clinical Trials

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%